Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 trial updating on efficacy and safety of secukinumab in adult patients with skin types IV-VI and moderate to severe plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Secukinumab (secukinumab)

Snippet

Sponsor: Saakshi Khattri | Conditions: Psoriasis | Phase 4 | Status: COMPLETED